OCCL2024-10-012024-12-31 OCCL2024-10-012024-12-31 OCCL2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member OCCL2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member OCCL2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 506579 OCCL NOTLISTED Oriental Carbon & Chemicals Limited Equity 2024-04-01 2025-03-31 2025-02-06 2025-01-31 INR Lakhs Third quarter 11:00:00 12:15:00 2025-02-06 2025-02-06 Not applicable Single segment Investments 2024-10-01 2024-12-31 Unaudited Standalone 91989000.00 4976000.00 96965000.00 0.00 49478000.00 0.00 5695000.00 34000.00 3855000.00 14312000.00 73374000.00 23591000.00 0.00 23591000.00 6437000.00 2109000.00 8546000.00 0.00 15045000.00 0.00 0.00 0.00 0.00 15045000.00 0.00 15045000.00 0.00 0.00 99901000.00 10 1.51 1.51 0.00 0.00 1.51 1.51 1. Pursuant to the scheme of demerger, chemical segment is treated as discontinued and the investment segment is treated as the only segment in the company and accordingly in the Group, investment and general engineering product are the business segments of the company. 2.The above results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meeting held on February 06' 2025. The limited review, as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, has been completed by the Statutory Auditors and they have expressed an unmodified opinion on the aforesaid results. 3. The Board of Directors of the Company at their meeting held on May 24' 2022 approved the Scheme of Arrangement under section 230-232 of the Companies Act,2013, of Demerger of Chemical business of Oriental Carbon & Chemicals Limited (Demerged Company) in to OCCL Limited (Resulting Company) and said scheme was approved by National Company Law Tribunal (NCLT), Ahmedabad and National Company Law Appellate Tribunal (NCLAT), New Delhi on April 10'2024 and May 27'2024 respectively. The appointed date and effective date of the Scheme is July 01'2024 (date of filing the certified copy of the Scheme with ROC). Accordingly the Accounting effect in respect of the Scheme has been given in these Financial Results as per the Scheme. The Company has accordingly charged the difference between carrying value of assets and liabilities amounting to Rs. 37,494.57 Lakhs (Loss) in the statement of profit and loss account as Exceptional Items - Profit/(Loss) in compliance with Ind AS 105, Non-current Assets Held for Sale and Discontinued Operations.As consideration for demerger, the resulting company has issued its equity shares to each shareholder of the demerged company as on record date in the ratio of 1:1 (i.e. 5 shares of Rs. 2 each have been issued by the resulting company for every one share of Rs. 10 each of demerged company). The net results of Manufacturing business of Insoluble Sulphur & Chemicals for comparative quarters/periods are disclosed separately as discontinued operations as required by Ind AS 105. 4. Subsequent to demerger as referred in note no. 3 above , the company has restated its Financial Statements/Results for all the periods as reported in the statement, during the quarter ending September 30, 2024 to disclose true and fair view of financials in accordance with Ind AS 8 (Accounting Policies, Changes in Accounting Estimates and Errors). Thus, fair value gains and losses from some Equity / AIF investments earlier measured as at Fair Value through Other Comprehensive income (FVTOCI) is reclassified to Fair Value through Profit or Loss (FVTPL), as outlined in Ind AS 109. These adjustments have impacted the financial results for the quarters and periods ending December 31, 2024, December 31, 2023 and 31 March 2024, presented as comparative information in the financial results. Due to above re-statement there is a shift of reserves from OCI to retained earnings. However, overall the reserves remain same. This restatement did not have any impact on the balance sheet. Table given below shows the impact of the restatement for the each of the periods presented along with the impact on Earnings per Share: For data, please refer pdf result 5. In line with the requirements of Regulation 47(2) of the Listing Regulations, 2015, the results are available on the Stock Exchange websites, www.bseindia.com/ www.nseindia.com and Company's website www.agventuresltd.com. Single segment 2024-04-01 2024-12-31 Unaudited Standalone 155638000.00 12448000.00 168086000.00 0.00 49478000.00 0.00 17570000.00 34000.00 11516000.00 45186000.00 123784000.00 44302000.00 -3749457000.00 -3705155000.00 18197000.00 18121000.00 36318000.00 0.00 -3741473000.00 105904000.00 30482000.00 75422000.00 0.00 -3666051000.00 9501000.00 -3656550000.00 0.00 0.00 99901000.00 10 -374.51 -374.51 7.55 7.55 -366.96 -366.96 Other expenses 14312000.00 Other expenses 45186000.00 0.00 6907000.00 0.00 -2594000.00 0.00 0.00